Dr. Sholl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis Street
Department of Pathology
Boston, MA 02115Phone+1 617-732-7510
Education & Training
- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2004 - 2008
- University of Pennsylvania Health SystemInternship, Internal Medicine, 2003 - 2004
- Stanford University School of MedicineClass of 2003
Certifications & Licensure
- MA State Medical License 2008 - 2025
- PA State Medical License 2003 - 2004
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 482 citationsAssociation of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of P...Brooke E. Howitt, Sachet A. Shukla, Lynette M. Sholl, Lauren L. Ritterhouse, Jaclyn C Watkins
JAMA Oncology. 2015-12-01 - 43 citationsTargeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomasJonathan J. Lee, Lynette M. Sholl, Neal I. Lindeman, Scott R. Granter, Alvaro C. Laga
Clinical Epigenetics. 2015-06-09 - 331 citationsInstitutional implementation of clinical tumor profiling on an unselected cancer populationLynette M. Sholl, Khanh T. Do, Priyanka Shivdasani, Ethan Cerami, Adrian M. Dubuc
JCI Insight. 2016-11-17
Journal Articles
- Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid TumorsJeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
- PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET Exon 14 Altered Lung CancersG J Riely, J Dienstag, C Mrad, J K Sabari, M G Kris, K C Arbour, D F Halpenny, N Rekhtman, R Chen, A J Plodkowski, P K Paik, B T Li, I Bergagnini, M D Offin, C M Rudin..., Annals of Oncology
- Validation of a Targeted Next-Generation Sequencing Approach to Detect Mismatch Repair Deficiency in Colorectal AdenocarcinomaLynette M Sholl, Amitabh Srivastava, Neal I Lindeman, Matthew B Yurgelun, Fei Dong, Nature
- Join now to see all
Authored Content
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase InhibitorsJanuary 2018
Press Mentions
- Computer Platform Helps Match Patients with Cancer to Trials of Targeted TherapyOctober 12th, 2022
- Highs, Lows of Tumor Mutation Burden TestingSeptember 20th, 2022
- Physicians’ Education Resource® to Present a Medical Crossfire®: Optimizing Pathological Assessment in Lung Cancer: A Focus on Patients with EGFR MutationsJuly 26th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: